Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tagrisso
Pharma
AZ's $80B revenue target 'very much within reach,' CFO says
AZ's oncology chief suggested the PD-L1 inhibitor Imfinzi will likely be the company's largest oncology medicine by sales “in the midterm period.”
Angus Liu
Jan 14, 2026 10:00am
FDA approves J&J's new challenge to Tagrisso
Dec 18, 2025 10:40am
AstraZeneca bolsters Tagrisso's case amid J&J rivalry
Sep 7, 2025 2:15am
AstraZeneca debuts TV ad for Tagrisso lung cancer treatment
Jul 23, 2025 1:37pm
AstraZeneca touts life-extension benefit for Tagrisso combo
Jul 21, 2025 2:59pm
J&J combo survival win signals new era in EGFR lung cancer
Mar 26, 2025 11:45am
